The relationship between cell surface markers, cytokines, ageing, and cigarette smoking

Bratislava Medical Journal

Volumn 110, Issue 7, 2009, Pages 394-400

  Horvathova, M ^a   Jahnova, E ^a   Szabova, M ^a   Tulinska, M ^a   Kuricova, M ^a   Liskova, A ^a   Volkovova, K ^a   Dusinska, M ^a  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

Ageing; Cell surface markers; Cytokines; Immune system; Smoking

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AGING; ARTICLE; BIOSYNTHESIS; HUMAN; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SMOKING;

ADULT; AGED; AGING; ANTIGENS, CD; CYTOKINES; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MIDDLE AGED; SMOKING; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 68649095875     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Alberti S et al. Age-dependent modifications of Type 1 and type 2 cytokines within virgin and memory CD4+ T cells in humans. Mech Ageing Dev 2006; 127: 560-566.
2. Alexeyev MF, Ledoux SP, Wilson GL. Mitochondrial DNA and aging. Clin Sci 2004; 107: 355-364.
3. Armstrong ME et al. Age-related alterations in basal expression and in vitro, tumour necrosis factor alpha mediated, upregulation of CDllb. Gerontology 2001; 47: 180-185.
4. Benanou D et al. Apoptosis and ageing. Mech Ageing Dev 1998; 102: 221-237.
5. Bernstein ED, Murasko DM. Effect of age on cytokine production in humans. Biomed Life Sci 2006; 21: 137-151.
6. Briggs NC et al. Cigarette smoking and risk of Hodgkin(s disease: A population-based case-control. Amer J Epidemiol 2002; 156:1011-1020.
7. Bruunsgaard H. Effects of tumor necrosis factor-alpha and interleu-kin-6 in elderly populations. Eur Cytokine Netw 2002; 13: 389-391.
8. Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Amer 2003; 23: 15-39.
9. Bryl E et al. Age-related increase of frequency of a new, phenotypically distinct subpopulation of human peripheral blood T cells expressing lowered levels of CD4. Blood 2001; 98: 1100-1107.
10. Butcher SK et al. Senescence in innate immune response: reduced ne-utrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol 2001; 70: 881-886.
11. Capri M et al. The genetics of human longevity. Ann NY Acad Sci 2006 a; 1067: 252-263.
12. Capri M et al. Complexity of anti-immunosenescence strategies in humans. Artif Organs 2006 b; 30: 730-742.
13. Capsoni F et al. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Res Ther 2005; 7: R250-R255.
14. Carreno BM et al. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol 2000; 165: 1352-1356.
15. Collaziol D et al. Psychoneuroendocrine correlates of lymphocyte subsets during healthy ageing. Mech Ageing Dev 2004; 125: 219-227.
16. Corrales JJ et al. Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications. J Diabet Complic 2007; 21: 41-49.
17. Cozen W et al. Thl and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption. J Clin Immunol 2004; 24: 617-622.
18. De Martinis M et al. Adhesion molecules on peripheral blood lymphocyte subpopulations in elderly. Life Sci 2000; 68: 139-151.
19. De Martinis M, Modesti M, Ginaldi L. Phenotypic and functional changes of circulating monocytes and polymorphonuclear leukocytes from elderly persons. Immunol Cell Biol 2004; 82: 415-20.
20. Dennett NS, Barcia RN, McLeod JD. Age associated decline in CD25 and CD28 expression correlate with an increased susceptibility to CD95 mediated apoptosis in T cells. Experim Gerontol 2002; 37: 271-283.
21. Dirks AJ, Leeuwenburgh C. Tumor necrosis factor alpha signalling in skeletal muscle: effects of age and caloric restriction. J Nutr Biochem 2006; 17: 501-508.
22. Fagiolo U et al. Increased cytokines production in mononuclear cells of healthy elderly people. Eur J Immunol 1993; 23: 2375-2378.
23. Fagnoni FF et al. Shortage of circulating nad've CD8+ T cells provides new insights on immunodeficiency in aging. Blood 2000; 95:2860-2868.
24. Fulop T Jr et al. Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system. Arthritis Res Ther 2003; 5: 290-302.
25. Ginaldi L et al. Immunophenotypical changes of T lymphocytes in the elderly.
26. Ginaldi L, Di Benetto MC, De Martinis M. Osteoporosis, inflammation and ageing. Immunity and Ageing 2005; 2: 14.
27. Giunta S. Is inflammaging an auto [innate] immunity subclinical syndrome? Immunity and Ageing 2006; 3: 12.
28. Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol 2007; 211: 144-156.
29. Hallquist N et al. Differential effects of nicotine and aging on spleno-cyte proliferation and the production of Thl- versus Th2-type cytokines. PSEBM 2000; 224: 141-146.
30. Herndon FJ, Hsu HC, Moutz JD. Increased apoptosis of CD45RO- T cells with aging. Mech Ageing Dev 1997; 94: 123-134.
31. Horner CC, Strunk RC. Age-related changes in the asthmatic pheno-type in children. Curr Opin Pediat 2007; 19: 295-299.
32. Chidrawar SM et al. Ageing is associated with a decline in peripheral blood CD56bright NK cells. Immunity Ageing 2006; 3: 10.
33. Il·yasova D et al. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 2005; 14: 2413-2418.
34. Imirzalioglu P et al. Cigarette smoking and apoptosis. J Periodontal 2005; 76: 737-739.
35. Jones RG et al. CD28-dependent activation of protein kinase B/akt blocks Fas-mediated apoptosis by preventing death-inducing signalling complex assembly. J Exp Med 2002; 196: 335-348.
36. Kalra R et al. Effects of cigarette smoke in immune response: chronic exposure to cigarette smoke impairs antigen-mediated signalling in T cells and depletes IP3-sensitive Ca(2+) stores. J Pharmacol Exp Ther 2000; 293: 166-171.
37. Karimi K et al. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Resp Res 2006; 7: 66.
38. Khwaja A, Carver JE, Linch DC. Interactions of granulocyt-macro-phage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor α in the priming of the neutrophil respiratory burst. Blood 1992; 79: 745-753.
39. Kirkwood TB, Austad SN. Why do we age? Nature 2000; 408: 233-238.
40. Kirkwood TB. Evolution of ageing. Mech Ageing Dev 2002; 123: 737-745.
41. Lambert C et al. Acrolein in cigarette smoke inhibits T-cell responses. J Allergy Clin Immunol 2005; 116: 916-922.
42. Leng Q, Betwich Z, Borkow G. CTLA-4 upregulation during aging. Mech Ageing Dev 2002; 123: 1419-1421.
43. Li Y et al. Neutrophil oygen radical generation. Synergistic Response to tumor necrosis factor and mono/polyunsaturated fatty acids. J Clin Invest 1996; 97: 1605-1609.
44. Licastro F et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immunity Ageing 2005; 2: 8.
45. Lio D et al. Tumor necrosis factor-alpha-308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech Ageing Dev 2006; 127: 567-571.
46. Lu LM et al. Cigarette smoke impairs NK cell-dependent tumor immune surveillance. J Immunol 2007; 15: 936-943.
47. Lupien SJ, Wan N. Successful ageing: from cell to self. Philos Trans R Soc Lond B Biol Sci 2004; 359: 1413-1426.
48. Mariani E et al. Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. Biogerontology 2006; 7: 449-459.
49. McAllister-Sistilli CG et al. The effects of nicotine on the immune system. Psychoneuroendocrinology 1998; 23: 175-187.
50. Mellon RD, Bayer BM. The effects of morphine, nicotine, and epibati-dine on lumphocyte activity and hypothalamic-pituitary-adrenal axis responses. J Pharmacol Exp Ther 1999; 288: 635-642.
51. Mooney J, Hodge PJ, Kinane DF. Humoral immune response in early-onset periodontitis: influence of smoking. J Periodontal Res 2001; 36: 227-232.
52. Morla M et al. Telomere shortening in smokers with and without COPD. Eur Resp J 2006; 27: 525-528.
53. Moszczynski P et al. Immunological findings in cigarette smokers. To-xicol Lett 2001; 118: 121-127.
54. Neuber K, Schmidt S, Mensch A. Telomere length measurement and determination of immunosenescence-related markers (CD28, CD45RO, CD45RA, interferon-gamma and interleukin-4) in skin-homing T cells expressing the cutaneous lymphocyte antigen: indication of a non-ageing t cell subset. Immunol 2003; 109: 24-31.
55. Noble JM, Ford GA, Thomas TH. Effect of aging on CD1lb and CD69 surface expression by vesicular insertion in human polymorphonuclear leukocytes. Clin Sci (Lond) 1999; 97: 323-329.
56. Palmer RM et al. Mechanism of action of environmental factors-tobacco smoking. J Clin Periodontol 2005; 32 (Suppl 6): 210-213.
57. Pawelec G. Immunity and ageing in man. Exp Gerontol 2006; 41:1239- 1242.
58. Peres A et al. Immunophenotyping and T-cell proliferation capacity in a healthy aged population. Biogerontology 2003; 4: 289-296.
59. Phaybouth V et al. Cigarette smoke suppresses Thl cytokine production and increases RSV expression in a neonatal model. Amer J Physiol Lung Cell Mol Physiol 2005; 290: L222-L231.
60. Pinti M et al. Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians. Cell Death Differentiation 2002; 9: 431-438.
61. Provinciali M, Smorlesi A. Immunoprevention and immunotherapy of cancer in ageing. Biom Life Sci 2005; 54: 93-106.
62. Schaberg T et al. Lymphocyte subsets in peripheral blood and smoking habits. Medicine 2004; 175: 387-394.
63. Suzuki N et al. Effects of cigarette smoking on Fas/Fas ligand expression of human lymphocytes. Cell Immunol 1999; 192: 48-53.
64. Tanigawa T et al. Increase in memory (CD4+CD29+ and CD4+CD45RO+) T and naive (CD4+CD45RA+) T-cell subpopulations in smokers. Arch Environ Health 1998; 53: 378-383.
65. Tappia PS et al. Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci (Lond) 1995; 88: 485-489.
66. Tarazona R et al. Basic biology and clinical impact of immunosenescen-ce. Exp Gerontol 2002; 37: 183-189.
67. Thompson-Cree M et al. The effect of nicotine on basophil histamine release. Inflamm Res 2004; 53: 211-214.
68. Trinchieri G et al. Cytokine cross-talk between phagocytic cells and lymphocytes: relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity. J Cell Biochem 1993; 53: 301-308.
69. Trzonkowski P et al. Lower percentage of CD8high+CD152+ but not CD8high+CD28+ T lymphocytes in elderly may be reverted by interleu-kin 2 in vitro. Mech Ageing Dev 2002; 123: 1283-1293.
70. Tsuji T, Aoshiba K, Nagai A. Cigarette smoke induces senescence in alveolar epithelial cells. Amer J Resp Cell Mol Biol 2004; 31: 643-649.
71. Tuder RM. Aging and cigarette smoke: Fueling the fire. Amer J Resp Crit Care Med 2006; 174: 490-491.
72. Tulinska J et al. The effect of ageing on modulation of immune response. International Conference on Environmental Epidemiology and Exposure, September 2-6, 2006, Paris, France. Abstract Book: 260, 2006.
73. Van der Vaart H et al. Acute effects of cigarette smoke on inflammation and oxidative stress. Thorax 2004; 59: 713-721.
74. Vassallo R et al. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 2005; 175: 2684-2691.
75. Vasto S, Caruso C. Immunity and ageing: a new journal looking at ageing from an immunological point of view. Immunity Ageing 2004; 1: 1.
76. Vasto S et al. Inflammatory networks in ageing, age-relared diseases and longevity. Mech Ageing Dev 2007; 128: 83-91.
77. Walker LSK et al. Down-regulation of CD28 via Fas (CD95): influence of CD28 on T-cell apoptosis. Immunol 1998; 94: 41-47.
78. Whetzel CA, Corwin EJ, Klein LC. Disruption in Thl/Th2 immune response in young adult smokers. Addict Behav 2007; 32: 1-8.
79. Wick G et al. Darwinian-evolutionary concept of age-related diseases. Experimental Gerontology 2003; 38: 13-25.
80. Zeidel A et al. Immune response in asymptomatic smokers. Acta Ana-esthesiol Scand 2002; 46: 959-964.
81. Zhang S, Petro TM. The effect of nicotine on murine CD4 T cell responses. Int J Immunopharmacol 1996; 18: 467-478.